MYELODYSPLASIA
Clinical trials for MYELODYSPLASIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One cord blood unit may replace two in stem cell transplants for blood cancer
Disease control CompletedThis study tested a new way to treat blood cancers like leukemia in 16 adults who did not have a standard bone marrow donor. Doctors used a single unit of cord blood that was grown in a lab to increase the number of stem cells before transplant. The goal was to see if this method…
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
Cord blood boost shows promise for tough leukemia cases
Disease control CompletedThis study tested a new method to make cord blood transplants work better for 30 people with high-risk leukemia or myelodysplasia. The approach uses a molecule called UM171 to help the donated stem cells grow faster, reducing recovery time and side effects. Early results suggest …
Matched conditions: MYELODYSPLASIA
Phase: PHASE2 • Sponsor: ExCellThera inc. • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Hidden heart risk in frequent blood transfusions revealed
Knowledge-focused CompletedThis study looked at how often heart iron buildup happens in people with thalassemia, sickle cell disease, or myelodysplasia who receive many blood transfusions. Researchers used MRI scans to measure iron in the heart and liver. The goal was to understand the problem better, not …
Matched conditions: MYELODYSPLASIA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC